Lachman Consultant Services, Inc., a leading provider of expert compliance, regulatory affairs, and technical services to life sciences organizations worldwide, will return to the International Society for Pharmaceutical Engineering’s 2019 Annual Meeting.
Westbury, NY – October 2019 Lachman Consultant Services, Inc. (“Lachman Consultants”), a leading provider of expert compliance, regulatory affairs, and technical services to life sciences organizations worldwide, will return to the International Society for Pharmaceutical Engineering’s (ISPE) 2019 Annual Meeting. Lachman Consultants is sponsoring the event on October 27-30 and will be located in booth #308 at the Caesars Palace Convention Center in Las Vegas, Nevada. The executive team on site will be hosting and leading sessions such as GMP Basics for Young Professionals and The Upcoming Transition of Biologic Products from NDAs to BLAs during the event.
Executives from Lachman Consultants participating at this year’s conference include Fran Zipp, President & CEO; Mary Oates, Vice President, Compliance Services; Linda Evans O’Connor, Vice President & Chief of Staff; Keith Webber, VP, Biotechnology; Dave Lonza, Head of EU; Paul Mason, Director of Science and Technology, among others. At this year’s meeting, Fran Zipp will be assuming her role as incoming Chair of the ISPE organization. “We’re excited to be returning to the ISPE Annual Meeting at a time when our industry is growing and innovating at such a rapid pace,” Zipp states. “That growth is driving the installation and retrofitting of facilities, equipment, systems, and the processes to support them. With a large number of global consultants, Lachman Consultants is well positioned to meet the growth demands throughout the world now, and well into the future.”
Lachman Consultants brings noteworthy experience and excellence to supporting companies in all consultative aspects of Auditing, FDA 483 Inspection & Warning Response, Regulatory Remediation, Data Governance & Integrity, and Quality Systems Implementation. Using a dedicated single-point-of-contact approach, multi-disciplinary groups of accomplished FDA and industry experts are assembled and involved from the firm’s Compliance, Regulatory, and Science and Technology Practice Groups to evaluate, advise, strategize, and help fulfill requirements wherever needed. Teams are selected and assigned according to each client’s specific set of objectives, needs, and circumstances.
“The ISPE organization has proved to be a significant resource for Lachman Consultants since the beginning,” notes Zipp. “With our growing presence and seasoned consultants throughout the world, clients have come to appreciate our regional adjacency, cultural familiarity, and most importantly, expertise in global pharma & biopharma regulatory and compliance requirements. ISPE helps us stay focused, up-to-date, innovative, and well-informed of the ever-changing global pharmaceutical markets.”
At the 2019 IPSE Annual Meeting, Lachman Consultants will be displaying its fluency and experience in Pharmaceuticals, Biotechnology, and Biologics. Visitors to Lachman Consultants’ Booth #308 will have the opportunity to meet with company executives to gain valuable insight into the company’s services.
ABOUT LACHMAN CONSULTANTS
Founded in 1978, Lachman Consultants maintains three practice groups: Compliance, Regulatory Affairs, and Science and Technology. Each practice offers industry-leading experience and expertise in its area of focus. Lachman Consultants serves emerging-to-enterprise organizations on a worldwide basis in the Pharmaceutical, Biotechnology, Biologics, Device, and Related Life Science Industries. Lachman Consultants deliver highly effective and proven solutions that include FDA-Related Services, Audits, Quality Assurance & Controls, Scientific and Technical Assistance, Systems Evaluation, and Training, which have been shown to consistently exceed client requirements and expectations.
For additional press information, please contact:
Ilena Della Ventura
Delia Associates
T. 908-534-9044
